SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000920465-21-000004
Filing Date
2021-02-02
Accepted
2021-02-02 17:18:24
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_161230428119904.html 4/A  
1 FORM 4/A wf-form4a_161230428119904.xml 4/A 6118
  Complete submission text file 0000920465-21-000004.txt   7510
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address
Hearne Michael S (Reporting) CIK: 0001759910 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36282 | Film No.: 21582672